Literature DB >> 27717219

Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement.

Joseph Scharpf1, Michael Tuttle2, Richard Wong2, Drew Ridge3, Russell Smith4, Dana Hartl5, Robert Levine6, Gregory Randolph7.   

Abstract

This American Head and Neck Society (AHNS) consensus statement focuses on the detection and management of recurrent thyroid cancer. This document describes the radiologic approach to defining structural recurrent disease and the operative and nonoperative rationale in addressing identified structural disease to create equipoise in the personalized treatment strategy for the patient. The recommendations of this AHNS multidisciplinary consensus panel of the American Head and Neck Society are intended to help guide all multidisciplinary clinicians who diagnose or manage adult patients with thyroid cancer. The consensus panel is comprised of members of the American Head and Neck Society and its Endocrine Surgical Committee, and there is representation from medical endocrinology and both national and international surgical representation drawn from general/endocrine surgery and otolaryngology/head and neck surgery. Authors provided expertise for their respective sections, and consensus recommendations were made regarding the evaluation and treatment of recurrent thyroid cancer. Evidence-based literature support is drawn from thyroid cancer studies, recurrent thyroid cancer studies, and American Thyroid Association (ATA) guidelines. The manuscript was then distributed to members of the American Head and Neck Society Endocrine Committee and governing counsel for further feedback.
© 2016 Wiley Periodicals, Inc. Head Neck 38: 1862-1869, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  nonoperative recurrent thyroid cancer management; recurrent thyroid cancer; reoperative thyroid surgery; thyroid cancer; thyroid cancer surveillance

Mesh:

Year:  2016        PMID: 27717219     DOI: 10.1002/hed.24513

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

Review 1.  Morbidity of central neck dissection for papillary thyroid cancer.

Authors:  Davide Lombardi; Remo Accorona; Alberto Paderno; Carlo Cappelli; Piero Nicolai
Journal:  Gland Surg       Date:  2017-10

2.  Cell penetrating peptide of sodium-iodide symporter effect on the I-131 radiotherapy on thyroid cancer.

Authors:  Yi-Xiang Fan; Zhi-Xin Liang; Qing-Zhu Liu; Han Xiao; Ke-Bin Li; Ji-Zhen Wu
Journal:  Exp Ther Med       Date:  2017-01-23       Impact factor: 2.447

Review 3.  Revision Thyroid Surgery.

Authors:  Karthik Nagaraja Rao; Satish Satpute; Nitin M Nagarkar; Ambesh Singh
Journal:  Indian J Surg Oncol       Date:  2021-11-04

Review 4.  Management of the Neck in Well-Differentiated Thyroid Cancer.

Authors:  Panagiotis Asimakopoulos; Ashok R Shaha; Iain J Nixon; Jatin P Shah; Gregory W Randolph; Peter Angelos; Mark E Zafereo; Luiz P Kowalski; Dana M Hartl; Kerry D Olsen; Juan P Rodrigo; Vincent Vander Poorten; Antti A Mäkitie; Alvaro Sanabria; Carlos Suárez; Miquel Quer; Francisco J Civantos; K Thomas Robbins; Orlando Guntinas-Lichius; Marc Hamoir; Alessandra Rinaldo; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

Review 5.  State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer.

Authors:  Horatiu Silaghi; Vera Lozovanu; Carmen Emanuela Georgescu; Cristina Pop; Bogdana Adriana Nasui; Adriana Florinela Cătoi; Cristina Alina Silaghi
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

6.  Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer.

Authors:  Andries H Groen; Deborah van Dijk; Wim Sluiter; Thera P Links; Hendrik P Bijl; John T M Plukker
Journal:  Eur Thyroid J       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.